Sanofi has announced that newly established API manufacturer EuroAPI will begin trading on the Euronext Paris on 6 May, subject to shareholder approval at a meeting three days before. Following this, EuroAPI will operate independently.
Huntsman shareholders have voted to elect all ten of its director nominees to the board at their AGM, giving the management an important victory over ‘activist’ shareholder Starboard, which had been trying to steer the firm in a different direction.
In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided its Health Care business into three distinct units.
Oilfield chemicals player Baker Hughes and Dussur, which is co-owned by Sabic and the Saudi Arabian Public Investment Fund, have signed an agreement to form a joint venture company to make oilfield and industrial chemicals in Saudi Arabia.
Barentz International has continued its ongoing series of acquisitions with two more distributors of life science ingredients and specialty chemicals, one based in France and the other in Latin America.
Greentech firm Afyren has announced the industrial commissioning of its Afyren Neoxy plant on schedule and within budget. The plant at Carling Saint-Avold in eastern France began construction in 2H 2020.
According to the German business newspaper Handelsblatt, the International Chemical Investors Group (ICIG) intends to sell CordenPharma. A valuation of around €3 billion has been cited. ICIG has, the paper said, has already had meetings with potential buyers and will send out information packs to them by the end January. Neither ICIG nor CordenPharma has made any comment.
Aceto has consolidated and integrated its six manufacturing-related acquisitions of recent years to achieve what it called “a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets”. These include (bio)pharmaceuticals, vaccines, nutraceuticals, agriculture, cosmetics and speciality chemicals. The six are:
* A&C, a global GMP manufacturer of speciality excipients, buffers, process solutions and raw materials for biopharmaceuticals
Following discussions with various parties about a sale of its Battery Materials business, Johnson Matthey (JM) has announced that it has not been able to reach an agreement to sell the business as a going concern. It is therefore beginning consultation with employees about proposed closure of the business and pursuing the sale of its individual assets.